FDA Inspection 1158379 — Steven Sussman, MD
The FDA completed an inspection of Steven Sussman, MD on November 19, 2021 in Lawrenceville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 19, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lawrenceville, NJ (United States)
Additional Details
Clinical Investigator (CI)